Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S FEXOFENADINE HYDROCHLORIDE ALLERGY versus CHILDREN S ZYRTEC HIVES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S FEXOFENADINE HYDROCHLORIDE ALLERGY versus CHILDREN S ZYRTEC HIVES.
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY vs CHILDREN'S ZYRTEC HIVES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fexofenadine is a selective peripheral H1-receptor antagonist. It inhibits histamine release from mast cells and basophils, reducing allergic symptoms.
Cetirizine is a selective antagonist of peripheral histamine H1 receptors, inhibiting histamine-mediated allergic reactions.
Fexofenadine hydrochloride 60 mg orally twice daily or 180 mg orally once daily.
5 mg or 10 mg orally once daily; maximum 10 mg/day.
None Documented
None Documented
14.4 hours (range 11-16 hours) in healthy adults; prolonged in renal impairment.
Terminal elimination half-life is approximately 8-11 hours in healthy adults, allowing twice-daily dosing.
Primarily fecal (80%) and renal (11%) as unchanged drug.
Cetirizine is primarily excreted renally (~60% unchanged), with ~10% fecal excretion.
Category A/B
Category C
Antihistamine
Antihistamine